Literature DB >> 12878532

In vitro activities of tigecycline (GAR-936) and 12 other antimicrobial agents against 90 Eikenella corrodens clinical isolates.

Emilia Cercenado1, Sonia Cercenado, Emilio Bouza.   

Abstract

The activity of tigecycline was compared with those of other antimicrobials against 90 isolates of Eikenella corrodens. The MIC at which 90% of the isolates were inhibited was 2 micro g/ml for tigecycline and 1, </=0.5/0.25, 0.5, </=0.12, </=2, and 0.5 micro g/ml for ampicillin, amoxicillin-clavulanate, cefotaxime, imipenem, chloramphenicol, and ciprofloxacin, respectively.

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 12878532      PMCID： PMC166070          DOI： 10.1128/AAC.47.8.2644-2645.2003

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


  23 in total

1.  Antimicrobial activity and spectrum of the new glycylcycline, GAR-936 tested against 1,203 recent clinical bacterial isolates.

Authors:  A C Gales; R N Jones
Journal:  Diagn Microbiol Infect Dis       Date:  2000-01       Impact factor: 2.803

2.  In vitro activities of the glycylcycline GAR-936 against gram-positive bacteria.

Authors:  H W Boucher; C B Wennersten; G M Eliopoulos
Journal:  Antimicrob Agents Chemother       Date:  2000-08       Impact factor: 5.191

3.  Comparative in vitro activities of GAR-936 against aerobic and anaerobic animal and human bite wound pathogens.

Authors:  E J Goldstein; D M Citron; C V Merriam; Y Warren; K Tyrrell
Journal:  Antimicrob Agents Chemother       Date:  2000-10       Impact factor: 5.191

Review 4.  Microbial etiological agents of destructive periodontal diseases.

Authors:  A D Haffajee; S S Socransky
Journal:  Periodontol 2000       Date:  1994-06       Impact factor: 7.589

5.  Trovafloxacin compared with levofloxacin, ofloxacin, ciprofloxacin, azithromycin and clarithromycin against unusual aerobic and anaerobic human and animal bite-wound pathogens.

Authors:  E J Goldstein; D M Citron; M Hudspeth; S Hunt Gerardo; C V Merriam
Journal:  J Antimicrob Chemother       Date:  1998-03       Impact factor: 5.790

6.  In vitro and in vivo antibacterial activities of a novel glycylcycline, the 9-t-butylglycylamido derivative of minocycline (GAR-936).

Authors:  P J Petersen; N V Jacobus; W J Weiss; P E Sum; R T Testa
Journal:  Antimicrob Agents Chemother       Date:  1999-04       Impact factor: 5.191

7.  DNA probe detection of periodontopathogens in advanced periodontitis.

Authors:  P O Söder; L J Jin; B Söder
Journal:  Scand J Dent Res       Date:  1993-12

Review 8.  Eikenella corrodens in human oral and non-oral infections: a review.

Authors:  C K Chen; M E Wilson
Journal:  J Periodontol       Date:  1992-12       Impact factor: 6.993

9.  Identification of a streptomycin resistance gene and a partial Tn3 transposon coding for a beta-lactamase in a periodontal strain of Eikenella corrodens.

Authors:  J M Lacroix; C B Walker
Journal:  Antimicrob Agents Chemother       Date:  1992-04       Impact factor: 5.191

10.  Comparison of broth microdilution method using Haemophilus test medium and agar dilution method for susceptibility testing of Eikenella corrodens.

Authors:  L Alcalá; F García-Garrote; E Cercenado; T Peláez; G Ramos; E Bouza
Journal:  J Clin Microbiol       Date:  1998-08       Impact factor: 5.948
View more
  1 in total

Review 1.  Antibiotics for treatment of resistant gram-positive coccal infections.

Authors:  Hossam Al-Tatari; Nahed Abdel-Haq; Pimpanada Chearskul; Basim Asmar
Journal:  Indian J Pediatr       Date:  2006-04       Impact factor: 5.319
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.